CORRECTED-Ambac Financial Q3 revenue falls on reduced earned premiums

Reuters
Nov 11
CORRECTED-Ambac Financial Q3 revenue falls on reduced earned premiums

Corrects Key Details table to show EBITDA and pretax profit figures are for the Insurance Distribution segment, not the whole company, and that the $43.22 mln refers to the segment's revenue, not gross written premiums for the company. Removes references to share repurchase and auto program from the Results Drivers section

Overview

  • Ambac Q3 revenue from continuing operations fell 5% due to reduced earned premiums

  • The insurance holding firm repurchased 3.1 mln shares in October, representing 6.7% of shares outstanding

Outlook

  • Company expects Everspan's combined ratios to improve between 2026 and 2027

  • Company sees significant growth potential with Pivix partnership expansion

Result Drivers

  • INSURANCE DISTRIBUTION GROWTH - Strong revenue growth in Insurance Distribution segment driven by organic growth and acquisition of Beat

  • ADVERSE LOSS EXPERIENCE - Specialty P&C Insurance segment affected by adverse loss experience

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Insurance Distribution Segment Revenue

$43.22 mln

Q3 Adjusted Net Income

-$9.96 mln

-$8.05 mln (1 Analyst)

Q3 Net Income

-$112.62 mln

Q3 Insurance Distribution Segment EBITDA

$9.86 mln

Q3 Insurance Distribution Segment Pretax Profit

-$5.75 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the property & casualty insurance peer group is "buy"

  • Wall Street's median 12-month price target for Ambac Financial Group Inc is $12.50, about 32.2% above its November 7 closing price of $8.48

Press Release: ID:nBw61JjH2a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10